Magdalena Wagner

Magdalena Wagner

Auto-generated profile, based on publicly available information

Magdalena Wagner

Division of Obstetrics and Gynecology, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Huddinge, Stockholm, Sweden

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 March 2020 in Nature Communications
Verified
Journal Article
Open access
PDF file
MWMagdalena Wagner
Magdalena Wagner
MYMasahito Yoshihara
Masahito Yoshihara
IDIyadh Douagi
Iyadh Douagi
ADAnastasios Damdimopoulos
Anastasios Damdimopoulos
SPSarita Panula
Sarita Panula
PDPauliina Damdimopoulou
Pauliina Damdimopoulou
The human ovary orchestrates sex hormone production and undergoes monthly structural changes to release mature oocytes. The outer lining of the ovary (cortex) has a key role in defining fertility in women as it harbors the ovarian reserve. It has been postulated that putative oogonial stem cells exist in the ovarian cortex and that these can be captured by DDX4 antibody isolation. Here, we report single-cell transcriptomes and cell surface antigen profiles of over 24,000 cells from high quality ovarian cortex samples from 21 patients. Our data identify transcriptional profiles of six main cell types; oocytes, granulosa cells, immune cells, endothelial cells, perivascular cells, and stromal cells. Cells captured by DDX4 antibody are perivascular cells, not oogonial stem cells. Our data do not support the existence of germline stem cells in adult human ovaries, thereby reinforcing the dogma of a limited ovarian reserve.

7 July 2020 in Archives of Toxicology
Verified
Journal Article
Open access
PDF file
HJHanna K. L. Johansson
Hanna K. L. Johansson
PDPauliina Damdimopoulou
Pauliina Damdimopoulou
MDMajorie Van Duursen
Majorie Van Duursen
JBJulie Boberg
Julie Boberg
DFDelphine Franssen
Delphine Franssen
TSTerje Svingen
Terje Svingen
Modern living challenges female reproductive health. We are witnessing a rise in reproductive disorders and drop in birth rates across the world. The reasons for these manifestations are multifaceted and most likely include continuous exposure to an ever-increasing number of chemicals. The cause–effect relationships between chemical exposure and female reproductive disorders, however, have proven problematic to determine. This has made it difficult to assess the risks chemical exposures pose to a woman’s reproductive development and function. To address this challenge, this review uses the adverse outcome pathway (AOP) concept to summarize current knowledge about how chemical exposure can affect female reproductive health. We have a special focus on effects on the ovaries, since they are essential for lifelong reproductive health in women, being the source of both oocytes and several reproductive hormones, including sex steroids. The AOP framework is widely accepted as a new tool for toxicological safety assessment that enables better use of mechanistic knowledge for regulatory purposes. AOPs equip assessors and regulators with a pragmatic network of linear cause–effect relationships, enabling the use of a wider range of test method data in chemical risk assessment and regulation. Based on current knowledge, we propose ten putative AOPs relevant for female reproductive disorders that can be further elaborated and potentially be included in the AOPwiki. This effort is an important step towards better safeguarding the reproductive health of all girls and women.

21 August 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
IRIlmatar Rooda
Ilmatar Rooda
JHJasmin Hassan
Jasmin Hassan
JHJie Hao
Jie Hao
MWMagdalena Wagner
Magdalena Wagner
EMElisabeth Moussaud-Lamodière
Elisabeth Moussaud-Lamodière
PDPauliina Damdimopoulou
Pauliina Damdimopoulou
The ovarian cortical reserve of follicles is vital for fertility. Some medical treatments are toxic to follicles, leading to premature ovarian insufficiency. Ovarian tissue cryopreservation is an established method to preserve fertility in adults and even applied in prepuberty despite unproven efficacy. Here, we analyze transcriptomes of 120 cortical follicles from children and adults for detailed comparison. We discover heterogeneity with two main types of follicles in both age groups: one with expected oocyte-granulosa profiles and another with predicted role in signaling. Transcriptional changes during growth to the secondary stage are similar overall in children and adults, but variations related to extracellular matrix, theca cells, and miRNA profiles are found. Notably, cyclophosphamide dose correlates with interferon signaling in child follicles. Additionally, morphology alone is insufficient for follicle categorization suggesting a need for additional markers. Marker genes for early follicle activation are determined. These findings will help refine follicular classification and fertility preservation techniques across critical ages.

1 June 2020 in Obstetrical & Gynecological Survey
Verified
Journal Article
Closed access
MWMagdalena Wagner
Magdalena Wagner
MYMasahito Yoshihara
Masahito Yoshihara
IDIyadh Douagi
Iyadh Douagi
ADAnastasios Damdimopoulos
Anastasios Damdimopoulos
SPSarita Panula
Sarita Panula
PDPauliina Damdimopoulou
Pauliina Damdimopoulou
(Abstracted from Nat Commun 2020;11:1147) In the female fetus, oogonia derived from fetal germ cells (FGCs) form primordial follicles that remain dormant until reactivation in the postnatal ovary. The reserve of primordial follicles in the ovarian cortex determines the fertile lifespan, and its depletion marks the beginning of menopause.

31 January 2021 in bioRxiv
Verified
Preprint
Open access
PDF file
RPReurer Sandra Petrus
Reurer Sandra Petrus
ALAlex R. Lederer
Alex R. Lederer
LBLaura Baqué-Vidal
Laura Baqué-Vidal
IDIyadh Douagi
Iyadh Douagi
BPBelinda Pannagel
Belinda Pannagel
FLFredrik Lanner
Fredrik Lanner
Human embryonic stem cell-derived retinal pigment epithelial cells (hESC-RPE) are a promising cell source to treat age-related macular degeneration (AMD). Despite several ongoing clinical studies, detailed single cell mapping of the transient cellular and molecular dynamics from the pluripotent state to mature RPE has not been performed. Here we conduct single-cell transcriptomic analyses of 25,718 cells during differentiation as well as in embryonic and adult retina references, revealing differentiation progression through an un-expected initial cell diversification recapitulating early embryonic development before converging towards an RPE lineage. We also identified NCAM1 to track and capture an intermediate retinal progenitor with the potential to give rise to multiple neuroepithelial lineages. Finally, we profiled hESC-RPE cells after subretinal transplantation into the rabbit eye, uncovering robust in vivo maturation towards an adult state. Our detailed evaluation of hESC-RPE differentiation supports the development of safe and efficient pluripotent stem cell-based therapies for AMD.

13 April 2020 in Human Reproduction
Verified
Journal Article
Open access
VPValentina Pampanini
Valentina Pampanini
MWMagdalena Wagner
Magdalena Wagner
BABabak Asadi-Azarbaijani
Babak Asadi-Azarbaijani
IOIrma C Oskam
Irma C Oskam
MSMona Sheikhi
Mona Sheikhi
KJKirsi Jahnukainen
Kirsi Jahnukainen